GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Accounts Payable & Accrued Expense

Qingdao Vland Biotech Co (SHSE:603739) Accounts Payable & Accrued Expense : ¥375 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co Accounts Payable & Accrued Expense?

Qingdao Vland Biotech Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥305 Mil) to Dec. 2023 (¥411 Mil) but then declined from Dec. 2023 (¥411 Mil) to Mar. 2024 (¥375 Mil).

Qingdao Vland Biotech Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥214 Mil) to Dec. 2022 (¥255 Mil) and increased from Dec. 2022 (¥255 Mil) to Dec. 2023 (¥411 Mil).

Qingdao Vland Biotech Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Qingdao Vland Biotech Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co Accounts Payable & Accrued Expense Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.69 187.02 214.03 255.36 411.40

Qingdao Vland Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.34 242.67 305.42 411.40 374.71

Qingdao Vland Biotech Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Qingdao Vland Biotech Co (SHSE:603739) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SZSE:300147 SZSE:300583 SZSE:301166 SZSE:300878 SZSE:300404 SZSE:000504 SHSE:688137 SHSE:605177 SZSE:000710 SZSE:300238 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061
Website
http://www.vlandgroup.com
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Executives
Chen Gang Director
Jia De Qiang Director
Cao Cheng Director
Jiang Yong senior management
Xu Yong Supervisors

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines